NADAC acquisition cost data for TERBINAFINE HCL 250 MG TABLET. This is a generic medication, typically more affordable than brand-name equivalents.
| Generic Name | Terbinafine HCl |
| Manufacturer | Darmerica, LLC |
| Dosage Form | POWDER |
| Product Type | BULK INGREDIENT |
| NDC | NADAC/Unit | Effective Date | Type |
|---|---|---|---|
| 42043041001 | $0.1513 | 2022-06-22 | Rx |
| 42043041003 | $0.1513 | 2022-06-22 | Rx |
| 42043041001 | $0.1513 | 2022-06-22 | Rx |
| 42043041003 | $0.1513 | 2022-06-22 | Rx |
| 16714079501 | $0.1606 | 2022-12-21 | Rx |
| 16714079502 | $0.1606 | 2022-12-21 | Rx |
| 51991052601 | $0.1606 | 2022-12-21 | Rx |
| 51991052633 | $0.1606 | 2022-12-21 | Rx |
| 62135057230 | $0.1606 | 2022-12-21 | Rx |
| 62135057290 | $0.1606 | 2022-12-21 | Rx |
Generic: Terbinafine HCl | Manufacturer: Overall
| Year | Total Spending | Claims | Beneficiaries | Cost/Unit |
|---|---|---|---|---|
| 2019 | $7.3M | 573,500 | 322,410 | $0.3338 |
| 2020 | $6.7M | 534,344 | 298,545 | $0.3221 |
| 2021 | $8.1M | 596,712 | 342,642 | $0.3381 |
| 2022 | $10.1M | 676,003 | 388,713 | $0.3578 |
| 2023 | $11.6M | 711,486 | 415,181 | $0.3841 |
The DrugPricePeek editorial team aggregates and verifies drugs data from CMS NADAC & Medicare Part D. Every statistic on this site is cross-referenced against the official source before publication, with quarterly re-verification cycles.
Read our full methodology or contact us with corrections.
Explore More Data Tools
For adjacent public-data tools, methodology notes, and network updates, visit DataPeek Facts.